跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,628 条关于
“Tim-4L”
全部
6,628
临床试验
5,675
药物
387
机构
39
资讯
527
去年
FDA Clears CERo Therapeutics' IND for Novel CAR-T Therapy CER-1236 in Solid Tumors
上个月
LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board as Oral TIM-3/TIM-4 Agonist Advances Through Phase 1b Trials
21天前
TIM-3 Identified as Common Culprit and Predictive Biomarker in Severe Bone Infections
去年
GSK's TIM-3 Inhibitor Cobolimab Fails Phase III Trial in Advanced Lung Cancer
去年
Novel TIM-3 Decoy Enhances CAR-T Cell Therapy Efficacy in B-Cell Acute Lymphoblastic Leukemia
2年前
Sabatolimab Shows Promise in Phase I/Ib Trial for Advanced Solid Tumors
8个月前
argenx Announces Leadership Transition as Karen Massey Set to Replace Tim Van Hauwermeiren as CEO
7个月前
Crystalys Therapeutics Appoints Former Horizon CEO Tim Walbert to Board as Gout Drug Advances Through Phase 3 Trials
去年
CERo Therapeutics' CER-1236 Shows Promise in Preclinical Ovarian Cancer Models
去年
Next-Generation Cancer Therapies: Advances in Checkpoint Inhibitors and Personalized Treatment
第 1 页,共 53 页
上一页
下一页